Genelux Corp Share Price Today: Live Updates & Key Insights

Genelux Corp share price today is $2.94, up -2.36%. The stock opened at $2.93 against the previous close of $2.96, with an intraday high of $2.93 and low of $2.86.

Genelux Corp Share Price Chart

Genelux Corp

us-stock
To Invest in {{usstockname}}
us-stock

Genelux Corp Share Price Performance

$2.94 -0.0236(-2.36%) GNLX at 27 Jul 2026 03:20 PM Biotechnology
Lowest Today 2.86
Highest Today 2.93
Today’s Open 2.93
Prev. Close 2.96
52 Week High 8.54
52 Week Low 2.29
Day’s Range: Low 2.86 High 2.93
52-Week Range: Low 2.29 High 8.54
1 day return -
1 Week return -2.37
1 month return +0.17
3 month return +12.06
6 month return +1.4
1 year return -14.79
3 year return -87.45
5 year return -
10 year return -

Genelux Corp Institutional Holdings

WOODWARD DIVERSIFIED CAPITAL, LLC 4.72

Vanguard Capital Management, LLC 3.78

Vanguard Group Inc 3.46

Bleichroeder LP 3.08

Vanguard Total Stock Mkt Idx Inv 2.66

Vanguard Institutional Extnd Mkt Idx Tr 1.04

Geode Capital Management, LLC 1.01

BlackRock Inc 0.91

Bank of America Corp 0.72

F.L.Putnam Investment Management 0.63

Vanguard Fiduciary Trust Co 0.56

CM Management, LLC 0.56

Global Retirement Partners, LLC. 0.48

Fidelity Extended Market Index 0.47

Northern Trust Corp 0.37

Provident Wealth Management, LLC 0.35

State Street Corp 0.33

LPL Financial Corp 0.31

iShares Micro-Cap ETF 0.31

UBS Group AG 0.27

Advisor Group Holdings, Inc. 0.27

LifeSteps Financial, Inc. 0.27

Blackrock Extended Mkt Fund CF 0.21

Extended Equity Market Fund B 0.21

Extended Equity Market Fund E 0.21

Morgan Stanley - Brokerage Accounts 0.20

BlackRock Extended Equity Market Fund K 0.18

Steel Peak Wealth Management LLC 0.17

Fidelity Total Market Index 0.14

Fidelity Series Total Market Index 0.13

Spartan Extended Market Index Pool F 0.13

Northern Trust Extended Eq Market Idx 0.11

NT Ext Equity Mkt Index Fund - Lending 0.11

NT Ext Equity Mkt Index Fund - NL 0.09

Goldman Sachs Absolute Ret Trckr Instl 0.06

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Spartan Total Market Index Pool G 0.06

Fidelity Nasdaq Composite Index 0.06

Northern Small Cap Core I 0.06

Vanguard Instl Ttl Stck Mkt Index Trust 0.06

Genelux Corp Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Genelux Corp Fundamentals

Market Cap 132.73 M

PB Ratio 5.7907

PE Ratio 0.0

Enterprise Value 109.01 M

Total Assets 19.03 M

Volume 153708

Genelux Corp Company Financials

Annual Revenue FY23:238000 0.2M, FY22:11068000 11.1M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY23:null 0.0M, FY22:11068000 11.1M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-25025000 -25.0M, FY22:-5207000 -5.2M, FY21:-17795000 -17.8M, FY20:-14864000 -14.9M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:452000 0.5M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-1000 -0.0M, Q3/2025:null 0.0M, Q2/2025:-143000 -0.1M, Q1/2025:-139000 -0.1M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-7125000 -7.1M, Q3/2025:-7950000 -8.0M, Q2/2025:-7456000 -7.5M, Q1/2025:-7492000 -7.5M, Q3/2024:-6467000 -6.5M

About Genelux Corp & investment objective

Company Information Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO Mr. Thomas D. Zindrick J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Genelux Corp FAQs

What is the share price of Genelux Corp today?

The current share price of Genelux Corp is $2.94.

Can I buy Genelux Corp shares in India?

Yes, Indian investors can buy Genelux Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Genelux Corp shares in India?

You can easily invest in Genelux Corp shares from India by:

Can I buy fractional shares of Genelux Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Genelux Corp?

Genelux Corp has a market cap of $132.73 M.

In which sector does Genelux Corp belong?

Genelux Corp operates in the Biotechnology sector.

What documents are required to invest in Genelux Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Genelux Corp?

The PE ratio of Genelux Corp is N/A and the PB ratio is 5.79.